Carmelita Abrahams

PhD candidate

CHI research group: Cardioprotection

Carmelita Abrahams is a PhD candidate within the Cardioprotection research group led by Prof Sandrine Lecour. Her research interests include cardio-oncology, cardiotoxicity, doxorubicin (DOX), and high-density lipoprotein particles. As part of her PhD, she established an in vivo mouse breast cancer model of DOX-induced cardiotoxicity. She is a member of the South African Heart Association and the International Society for Heart Research.

Research engagements:

Mechanisms for DOX-induced cardiotoxicity
Cardioprotection against DOX-induced cardiotoxicity